Sec Form 13G Filing - Forager Fund L.P. filing for QUIPT HOME MED CORP COM (QIPT) - 2024-12-11

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

 

(Amendment No. __)*

 

Quipt Home Medical Corp.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

74880P104

(CUSIP Number)

 

June 6, 2024

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 

Rule 13d-1(b)

 

 

 

 

Rule 13d-1(c)

 

 

 

 

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

CUSIP No. 74880P104

Page 2 of 7 Pages

 

1

NAME OF REPORTING PERSONS

 

Forager Fund, L.P.

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ☐ (b) ☐

3

SEC USE ONLY

 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

2,129,970

6

 

SHARED VOTING POWER

 

7

 

SOLE DISPOSITIVE POWER

 

2,129,970 

8

 

SHARED DISPOSITIVE POWER

 

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,129,970 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.0%(1)

12

 

TYPE OF REPORTING PERSON (See Instructions)

 

PN

 

(1)

Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

 

 

 

 

CUSIP No. 74880P104

Page 3 of 7 Pages

 

1

NAME OF REPORTING PERSONS

 

Forager Capital Management, LLC 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ☐ (b) ☐ 

3

 

SEC USE ONLY

 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware 

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

5

 

SOLE VOTING POWER

 

2,129,970(1) 

6

 

SHARED VOTING POWER

 

7

 

SOLE DISPOSITIVE POWER

 

2,129,970(1)

8

 

SHARED DISPOSITIVE POWER

 

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,129,970(1) 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.0%(2)

12

 

TYPE OF REPORTING PERSON (See Instructions)

 

IA

 

(1)

Shares reported in this table are held by Forager Fund, L.P., of which the Reporting Person is the general partner.

(2)

Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

 

 

 

 

CUSIP No. 74880P104

Page 4 of 7 Pages

 

1

 

NAME OF REPORTING PERSONS

 

Edward Kissel

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ☐ (b) ☐

3

 

SEC USE ONLY

 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

5

 

SOLE VOTING POWER

 

0

6

 

SHARED VOTING POWER

 

2,129,970(1)

7

 

SOLE DISPOSITIVE POWER

 

8

 

SHARED DISPOSITIVE POWER

 

2,129,970(1)

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,129,970(1) 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.0%(2)

12

 

TYPE OF REPORTING PERSON (See Instructions)

 

HC; IN 

 

(1)

These shares are held by Forager Fund, L.P., of which Forager Capital Management, LLC is the general partner. The Reporting Person is a managing partner of Forager Capital Management, LLC.

(2)

Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

 

 

 

 

CUSIP No. 74880P104

Page 5 of 7 Pages

 

1

 

NAME OF REPORTING PERSONS

 

Robert MacArthur

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

(a) ☐ (b)☐ 

3

 

SEC USE ONLY

 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

5

 

SOLE VOTING POWER

 

0

6

 

SHARED VOTING POWER

 

2,129,970(1)

7

 

SOLE DISPOSITIVE POWER

 

0

8

 

SHARED DISPOSITIVE POWER

 

2,129,970(1)

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,129,970(1) 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.0%(2)

12

 

TYPE OF REPORTING PERSON (See Instructions)

 

HC; IN

 

(1)

These shares are held by Forager Fund, L.P., of which Forager Capital Management, LLC is the general partner. The Reporting Person is a managing partner of Forager Capital Management, LLC.

(2)

Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

 

 

 

 

CUSIP No. 74880P104

Page 6 of 7 Pages

 

ITEM 1(a).

NAME OF ISSUER

 

 

 

Quipt Home Medical Corp. (the “Issuer”)

 

 

ITEM 1(b).

ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

 

 

 

1019 Town Drive

Wilder, Kentucky 41076

 

 

ITEM 2(a).

NAME OF PERSONS FILING

 

 

 

This joint statement on Schedule 13G is being filed by Forager Fund, L.P., a Delaware limited partnership (the “Fund”), Forager Capital Management, LLC, a Delaware limited liability company and the general partner of the Fund (the “General Partner”), Edward Kissel and Robert MacArthur (collectively, the “Reporting Persons”).

 

 

 

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

 

ITEM 2(b).

ADDRESS OF PRINCIPAL BUSINESS OFFICE

 

 

 

The business address of each of the Reporting Persons is 2025 3rd Ave. N, Suite 350, Birmingham, AL 35203.

 

 

ITEM 2(c).

CITIZENSHIP

 

 

 

The Fund is a Delaware limited partnership. The General Partner is a Delaware limited liability company. Each of Messrs. Kissel and MacArthur is a citizen of the United States.

 

 

ITEM 2(d).

TITLE OF CLASS OF SECURITIES

 

 

 

Common stock (the “Common Stock”).

 

 

ITEM 2(e).

CUSIP NUMBER

 

 

 

74880P104

 

 

ITEM 3.

Not applicable.

 

 

ITEM 4.

OWNERSHIP

 

 

 

The Reporting Persons, in the aggregate, beneficially own 2,129,970 shares of Common Stock of the Issuer, representing approximately 5.0% of such class of securities. The beneficial ownership of each Reporting Person is as follows: each of the Fund, the General Partner and Messrs. Kissel and MacArthur beneficially owns 2,129,970 shares of Common Stock representing approximately 5.0% of the class. The percentages of beneficial ownership reported herein, and on each Reporting Person’s cover page to this Schedule 13G, are based on a total of 42,571,000 shares of Common Stock as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

 

 

 

  

CUSIP No. 74880P104

Page 7 of 7 Pages

 

 

Each of the Fund and the General Partner has the sole power to vote and dispose of 2,129,970 shares of Common Stock. Each of Messrs. Kissel and MacArthur has the shared power to vote and dispose of 2,129,970 shares of Common Stock. The amounts and percentages of beneficial ownership reported herein are as of June 6, 2024.

 

 

ITEM 5.

OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

 

 

 

Not applicable.

 

 

ITEM 6.

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

 

 

 

Not applicable.

 

 

ITEM 7.

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON

 

 

 

Not applicable.

 

 

ITEM 8.

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

 

 

 

Not applicable.

 

 

ITEM 9.

NOTICE OF DISSOLUTION OF GROUP

 

 

 

Not applicable.

 

 

ITEM 10.

CERTIFICATION

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

   

 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

DATE:

December 11, 2024

 

 

 

 

 

 

FORAGER FUND, L.P.

 

 

 

 

 

 

By:

Forager Capital Management, LLC,

 

 

 

its General Partner

 

 

 

 

 

 

By:

/s/ Robert MacArthur

 

 

 

Robert MacArthur

 

 

 

Managing Partner

 

 

 

 

 

 

FORAGER CAPITAL MANAGEMENT, LLC 

 

 

 

 

 

 

By:

/s/ Robert MacArthur

 

 

 

Robert MacArthur

 

 

 

Managing Partner

 

 

 

 

 

 

EDWARD KISSEL

 

 

 

 

 

 

/s/ Edward Kissel

 

 

Edward Kissel

 

 

 

 

 

 

ROBERT MACARTHUR 

 

 

 

 

 

 

/s/ Robert MacArthur

 

 

Robert MacArthur

 

 

 

 

 

Exhibit 1

 

JOINT FILING AGREEMENT

 

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree, as of December 11, 2024, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of common stock of Quipt Home Medical Corp., a British Columbia, Canada corporation, and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.

 

 

FORAGER FUND, L.P.

 

 

 

 

 

 

By:

Forager Capital Management, LLC,

 

 

 

its General Partner

 

 

 

 

 

 

By:

/s/ Robert MacArthur

 

 

 

Robert MacArthur

 

 

 

Managing Partner

 

 

 

 

 

 

FORAGER CAPITAL MANAGEMENT, LLC 

 

 

 

 

 

 

By:

/s/ Robert MacArthur

 

 

 

Robert MacArthur

 

 

 

Managing Partner

 

 

 

 

 

 

EDWARD KISSEL

 

 

 

 

 

 

/s/ Edward Kissel

 

 

Edward Kissel

 

 

 

 

 

 

ROBERT MACARTHUR 

 

 

 

 

 

 

/s/ Robert MacArthur

 

 

Robert MacArthur

 

 

 

 

 

Exhibit 2

 

CONFIRMING STATEMENT

 

This Statement confirms that the undersigned has authorized and designated Robert MacArthur to execute and file on the undersigned’s behalf all Forms 3, 4 and 5 and Schedules 13D and 13G (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of Quipt Home Medical Corp., a British Columbia, Canada corporation.  The authority of Robert MacArthur under this Statement shall continue until the undersigned is no longer required to file any of Forms 3, 4 and 5 and Schedules 13D and 13G with regard to the undersigned’s ownership of or transactions in securities of Regional Management Corp., unless earlier revoked in writing.  The undersigned acknowledges that Robert MacArthur is not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 of the Securities Exchange Act of 1934, as amended.

 

Dated: December 11, 2024 /s/ Edward Kissel

 

 

Edward Kissel  

 

 

 

 

Exhibit 3

 

CONFIRMING STATEMENT

 

This Statement confirms that the undersigned has authorized and designated Edward Kissel to execute and file on the undersigned’s behalf all Forms 3, 4 and 5 and Schedules 13D and 13G (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of Quipt Home Medical Corp., a British Columbia, Canada corporation.  The authority of Edward Kissel under this Statement shall continue until the undersigned is no longer required to file any of Forms 3, 4 and 5 and Schedules 13D and 13G with regard to the undersigned’s ownership of or transactions in securities of Regional Management Corp., unless earlier revoked in writing.  The undersigned acknowledges that Edward Kissel is not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 of the Securities Exchange Act of 1934, as amended.

 

Dated: December 11, 2024 

 

/s/ Robert MacArthur

 

 

 

Robert MacArthur